| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1,577.0 | 1,594.0 |
| Gross profit | 638.0 | 658.0 |
| Profit before tax | 49.0 | 103.0 |
| Net income | 38.0 | 77.0 |
| EPS (diluted, $ a share) | $0.19 | $0.37 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -50.6% |
|---|---|
| Revenue, year on year | -1.1% |
| Gross margin | 40.5% |
| Operating margin | 6.8% |
10-Q filed with the SEC, NYSE: BBWI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Bath & Body Works, Inc.: key numbers
- Share price
- $18.66Close, Nov 20
- Market cap
- $3.74B
- Shares outstanding
- 201.65MLatest SEC cover page
- Sector
- Trade & Services
- Industry
- Retail-Retail Stores, NECSIC 5990
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Bath & Body Works, Inc.
All →Bath & Body Works Financial Results
Bath & Body Works reported Q3 2026 net sales of $1.6 billion and adjusted EPS of $0.26, exceeding its previous guidance. The company also announced a new $500 million share repurchase program and raised its full-year 2026 net sales outlook.
“Our third quarter results exceeded our sales and adjusted earnings per share guidance, and marks encouraging progress in our Consumer First Formula. One year after introducing this strategy, we are seeing our actions translate into results across product, brand, and marketplace.”
Daniel Heaf, chief executive officer of Bath & Body Works
“We are one year into a multi-year transformation, and progress will not always be linear. As we approach the important holiday season, we are taking a prudent view of the consumer environment while remaining focused on execution.”
Daniel Heaf, chief executive officer of Bath & Body Works
Bath & Body Works Stock Plan Amendment
Bath & Body Works granted a performance stock unit (PSU) award with a target value of $10 million to its CEO, Daniel Heaf. The award is tied to rigorous stock price performance hurdles ranging from $40 to $100 per share over a four-year performance period and includes a total shareholder return (TSR) modifier.
- Counterparty
- Daniel Heaf
- Term
- 4 years